As of April 2024 EyePoint Pharmaceuticals has a market cap of $0.82 Billion. This makes EyePoint Pharmaceuticals the world's 5373th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.82 B | -27.28% |
2023 | $1.12 B | 846.15% |
2022 | $0.11 B | -71.25% |
2021 | $0.41 B | 316.78% |
2020 | $99.55 M | -41.3% |
2019 | $0.16 B | -5.91% |
2018 | $0.18 B | 268.79% |
2017 | $48.87 M | -16.37% |
2016 | $58.44 M | -59.08% |
2015 | $0.14 B | 18.13% |
2014 | $0.12 B | 11.54% |
2013 | $0.10 B | 284.46% |
2012 | $28.18 M | 22.08% |
2011 | $23.09 M | -75.62% |
2010 | $94.69 M | 43.19% |
2009 | $66.13 M | 285.24% |
2008 | $17.16 M | 2874.6% |
2007 | $0.57 M | -25.96% |
2006 | $0.77 M | -99.63% |
2005 | $0.20 B |
On Apr 23rd, 2024 the market cap of EyePoint Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $18.25 M | -97.78% | Bahamas |
NRC Health
NRC | $0.81 B | -1.11% | ๐บ๐ธ USA |